Phase II study of the activity and tolerability of a combined regimen of high-dose epirubicin and cisplatin in stage IIIb and IV non-small cell lung cancer

M. Clerici, F. De Marinis, E. Piazza, L. Frontini, E. Tucci, S. Barni, S. Bretti, G. Luporini, C. Intini

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase II study of the activity and tolerability of a combined regimen of high-dose epirubicin and cisplatin in stage IIIb and IV non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences